Under which plan was the PATHWARD FINANCIAL (CASH) share grant to Lizabeth H. Zlatkus made?

The 1,650-share grant to PATHWARD FINANCIAL director Lizabeth H. Zlatkus was made under the company’s 2023 Omnibus Incentive Plan. The footnote specifies this equity plan as the source of the award, confirming it as part of the company’s standard incentive compensation program.

Pathward Financial director awarded 1,650 shares

Zlatkus Lizabeth H reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/25/2026 - 04:14 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Zlatkus Lizabeth H reported acquisition or exercise transactions in this Form 4 filing.

PATHWARD FINANCIAL, INC. director Lizabeth H. Zlatkus received a grant of 1,650 shares of common stock on February 24, 2026 under the company’s 2023 Omnibus Incentive Plan. Following this award, her directly held common stock increased to a total of 15,000 shares.

Insider Trade Summary

Grant/Award: 1,650 shares

Grant/Award 1 txn

Insider Zlatkus Lizabeth H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,650	$0.00	$0.00

Holdings After Transaction: Common Stock — 15,000 shares (Direct)

Holdings Before and After: Common Stock, 13,350 to 15,000 shares (Direct)

Footnotes (1)

F1. Award pursuant to the Company's 2023 Omnibus Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PATHWARD FINANCIAL (CASH) report for Lizabeth H. Zlatkus?

PATHWARD FINANCIAL reported that director Lizabeth H. Zlatkus received a grant of 1,650 shares of common stock. This grant was classified as a non-derivative award and increased her directly held position to 15,000 common shares after the transaction.

When did the PATHWARD FINANCIAL (CASH) director stock award occur?

The stock award to PATHWARD FINANCIAL director Lizabeth H. Zlatkus occurred on February 24, 2026. On that date, she was granted 1,650 common shares, recorded as an award acquisition under the company’s equity plan, raising her direct holdings to 15,000 shares.

How many PATHWARD FINANCIAL (CASH) shares does Lizabeth H. Zlatkus own after the grant?

After the reported grant, director Lizabeth H. Zlatkus directly owns 15,000 PATHWARD FINANCIAL common shares. This total reflects the addition of 1,650 shares awarded on February 24, 2026, as part of a non-cash stock grant under the company’s 2023 Omnibus Incentive Plan.

What was the price for the PATHWARD FINANCIAL (CASH) stock award to Lizabeth H. Zlatkus?

The reported grant of 1,650 PATHWARD FINANCIAL common shares to director Lizabeth H. Zlatkus carried a transaction price per share of $0.0000. This indicates a compensatory stock award rather than an open-market purchase, issued under the 2023 Omnibus Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zlatkus Lizabeth H

(Last)

(First)

(Middle)

C/O PATHWARD FINANCIAL, INC.

5501 S BROADBAND LANE

(Street)

SIOUX FALLS

57108

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PATHWARD FINANCIAL, INC. [ CASH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/24/2026		A		1,650⁽¹⁾	A	$0	15,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Award pursuant to the Company's 2023 Omnibus Incentive Plan.

Remarks:

	/s/ Chance Huber, attorney-in-fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR